PROGRAMME EHMSG Workshop
Friday, September 13, 2024
08.25 – 08.30 hrs | Welcome by EHMSG President José Machado
08.30 – 10.30 hrs | Session 1: Hot topics in H.pylori and gut microbiota
08.30 – 08.50 hrs
1.1. The person-to-person transmission landscape of the gut and oral microbiomes
Vitor Heidrich, Italy
08.50 – 09.10 hrs
1.2. New drugs targeting H. pylori envelopes
Ivo Boneca, France
09.10 – 09.30 hrs
1.3. Evolving concepts in H. pylori management
Shailja Shah, United States
09.30 – 09.50 hrs
1.4. CAR-T Therapy & Microbiome
tba
09.50 – 10.10 hrs
1.5. Evolution of the prevalence and incidence of Helicobacter pylori infection
Jyh-Ming Liou, Taiwan
10.10 – 10.30 hrs
1.6. GWAS on H. pylori seroprevalence
Constanza Camargo, Rockville, MD, United States
10.30 – 11.00 hrs | Coffee Break
11.00 – 12.45 hrs | Session 2: News on gastritis (Parallel Session)
11.00 – 11.20 hrs
02.01 The RE.GA.IN consensus project
Massimo Rugge, Italy
11.20 – 11.40 hrs
02.02 Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients
Ludovica Bricca, Italy
11.40 – 12.00 hrs
02.03 Trends in the prevalence of atrophic gastritis and Helicobacter pylori in Far East
Yoshio Yamaoka, Japan
12.00 – 12.15 hrs
Talk from submitted abstracts
12.15 – 12.30 hrs
Talk from submitted abstracts
12.30 – 12.45 hrs
Talk from submitted abstracts
11.00 – 12.45 hrs |Session 3: Microbiome mechanisms of action (Parallel Session)
11.00 – 11.20 hrs
03.01 Protein fermentation products and health outcomes
Silvio Waschina, Kiel, Germany
11.20 – 11.40 hrs
03.02 Mechanisms of microbiome engraftment
Gianluca Ianiro, Italy
11.40 – 12.00 hrs
03.03 Mycobiome in IBD
Petra Bacher, Germany
12.00 – 12.15 hrs
Talk from submitted abstracts
12.15 – 12.30 hrs
Talk from submitted abstracts
12.30 – 12.45 hrs
Talk from submitted abstracts
12.45 – 14.00 hrs | Lunch Break & Poster Viewing
14.00 – 15.00 hrs | Session 4: Industry-Sponsored Satellite Symposium
15.00 – 16.45 hrs | Session 5: Helicobacter pylori: Genetics and Beyond (Parallel Session)
15.00 – 15.20 hrs
05.01 Differences in H. pylori population structures worldwide
Kaisa Thorell, Sweden
15.20 – 15.40 hrs
05.02 H. pylori evolution depends on niche specific physiological conditions
Sebastian Suerbaum, Germany
15.40 – 16.00 hrs
05.03 Impact of H. pylori on mucosal immunity and colorectal cancer
Markus Gerhard, Germany
16.00 – 16.15 hrs
Talk from submitted abstracts
16.15 – 16.30 hrs
Talk from submitted abstracts
16.30 – 16.45 hrs
Talk from submitted abstracts
15.00 – 16.45 hrs | Session 6: Oncobiome (Parallel Session)
15.00 – 15.20 hrs
06.01 Microbiome mediated inflammation in colon cancer
Mathias Chamaillard, Lille, France
15.20 – 15.40 hrs
06.02 Predicting CRC survival post-surgical resection using tumour microbial profiling
James Alexander, United Kingdom
15.40 – 16.00 hrs
06.03 Microbiota-modulated immune checkpoint
Carolina Alves Costa Silva, France
16.00 – 16.15 hrs
Talk from submitted abstracts
16.15 – 16.30 hrs
Talk from submitted abstracts
16.30 – 16.45 hrs
Talk from submitted abstracts
16.45 – 17.15 hrs | Coffee Break
17.15 – 19.00 hrs | Session 7: Gastric Carcinogenesis (Parallel Session)
17.15 – 17.35 hrs
07.01 Microbiome and gastric cancer
Ceu Figueiredo, Portugal
17.35 – 17.55 hrs
07.02 Innocent Bystander as a Precancerous Condition for Gastric Cancer?
Ken Sugano, Japan
17.55 – 18.15 hrs
07.03 Natural History of Sporadic and Hereditary Diffuse Gastric Carcinoma: From Onset to Progression
Fatima Carneiro, Portugal
18.15 – 18.30 hrs
Talk from submitted abstracts
18.30 – 18.45 hrs
Talk from submitted abstracts
18.45 – 19.00 hrs
Talk from submitted abstracts
17.15 – 19.00 hrs | Session 8: FMT session (Parallel Session)
17.15 – 17.35 hrs
08.01 Safety in FMT
Josbert Keller, Netherlands
17.35 – 17.55 hrs
08.02 Regulation of FMT and donor screening
Christian Hvas, Denmark
17.55 – 18.15 hrs
08.03 How to improve FMT success
Alexander Link, Germany
15.15 – 18.30 hrs
Talk from submitted abstracts
18.30 – 18.45 hrs
Talk from submitted abstracts
18.45 – 19.00 hrs
Talk from submitted abstracts
20.00 hrs
EHMSG Conference Dinner
Saturday, September 14, 2024
08.30 – 09.15 hrs | Session 9: Memorial Talks
08.30 – 08.45 hrs
09.01 In Memoriam Ashley Price
Anthony Axon, United Kingdom
08.45 – 09.00 hrs
09.02 In Memoriam Pentti Sipponen
Ari Ristimäki, Finland
09.00 – 09.15 hrs
09.03 In Memoriam Adrian Lee
Jim Fox, United States
09.15 – 11.00 hrs | Session 10: H. pylori management (Parallel Session)
09.15 – 09.35 hrs
10.01 Current role of tailored therapy in treating H. pylori infection
Theodore Rokkas, Greece
09.35 – 09.55 hrs
10.02 The rebirth of Bismuth in H. pylori eradication
Rocco Maurizio Zagari, Italy
09.55 – 10.15 hrs
10.03 Latin American Registry on the Management of H. pylori Infection (Hp-LATAMReg)
Arnoldo Riquelme, Chile
10.15 – 10.30 hrs
Talk from submitted abstracts
10.30 – 10.45 hrs
Talk from submitted abstracts
10.45 – 11.00 hrs
Talk from submitted abstracts
09.15 – 11.00 hrs | Session 11: Probiotics (Parallel Session)
09.15 – 09.35 hrs
11.01 Use of probiotics in chronic liver diseases
Luca Miele, Italy
09.35 – 09.55 hrs
11.02 Inflammatory bowel diseases: when can probiotics be helpful?
Loris Lopetuso, Italy
09.55 – 10.15 hrs
11.03 New probiotics: where is the future?
tba
10.15 – 10.30 hrs
Talk from submitted abstracts
10.30 – 10.45 hrs
Talk from submitted abstracts
10.45 – 11.00 hrs
Talk from submitted abstracts
11.00 – 11.30 hrs | Coffee Break
11.30 – 13.30 hrs | Session 12: Debates – Gastric cancer screening
11.30 – 11.50 hrs
12.01 Optimal strategies for gastric cancer screening – targeted vs. population based
Iris Lansdorp Vogelaar, Netherlands
11.50 – 12.10 hrs
12.02 What is the optimal age for screening?
Jan Bornschein, United Kingdom
12.10 – 12.30 hrs
12.03 Is there a role for endoscopy and AI in gastric cancer screening
Mario Dinis Ribeiro, Portugal
12.30 – 12.50 hrs
10.04 Gastric cancer screening experience in Japan
Hidekazu Suzuki , Japan
12.50 – 13.10 hrs
10.05 Helicobacter pylori Treatment and Gastric Cancer Risk After Endoscopic Resection of Dysplasia: A Nationwide Cohort Study
Hae Won Yoo, Korea
13.10 – 13.30 hrs
10.06 Linqu county study status
Wen Qing Li, China
13.30 – 15.00 hrs | Lunch Break & Poster Viewing
15.00 – 17.00 hrs |Session 13: Updates in Helicobacter & Microbiota
15.00 – 15.20 hrs
13.01 Million Microbiome from Humans Project
Lars Engstrand, Sweden
15.20 – 15.40 hrs
13.02 Machine Learning for Microbiome analysis
tba
15.40 – 16.00 hrs
13.03 Effect of faecal microbiota transplantation on multidrug-resistant bacteria and the resistome
Elizabeth Terveer, The Netherlands
16.00 – 16.20 hrs
13.04 The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection
Cristina Martins, Portugal
16.20 – 16.40 hrs
13.05 Novel principles for cure of H. pylori infection
Peter Malfertheiner, Germany
16.40 – 17.00 hrs
13.06 Histamine Signaling Is Essential for Tissue Macrophage Differentiation and Suppression of Bacterial Overgrowth in the Stomach Cell
Ki Taek Nam, Korea
17.00 – 18.00 hrs | Session 14: Closing Session
17.00 – 17.20 hrs
14.01 Awarding of the Marshall and Warren Medal 2024 to Fatima Carneiro, Porto, Portugal
17.20 – 17.35 hrs
14.02 Awarding of the EHMSG Oral and Poster Awards
17.35 – 17.50 hrs
14.03 Presentation of the EHMSG Journal
Francesco Franceschi, Italy
17.50 – 18.00 hrs
14.04 Presentation of the next meeting in Rome
Closing Remarks